Global Cancer Therapeutics Market Report - Phase I-III Pipeline Analysis with Markets by Segment

Dec 31, 2015, 07:10 ET from Research and Markets

DUBLIN, Dec. 31, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/r2jnfb/the_world_market) has announced the addition of the "The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment (Lung, Breast, Prostate, Cervical, Brain, Bladder, Lymphoma, Colon, O" report to their offering.

This report, the World Market for Cancer Therapeutics provides an in-depth analysis of the market for cancer drugs, with a focus on novel therapies. This includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Colon Cancer and Other types) including Monoclonal Antibodies, Tyrosine Kinase, Inhibitors, Cancer Vaccines, Cytokines, Gene Therapy, Traditional Chemotherapy.

Secondary and primary research was used to determine market size for cancer types by product sales in this report. Methodology included telephone interviews and email correspondence with company representatives, researchers, government representatives, and physicians. These interviews were conducted with the purpose of capturing the perspectives from industry participants on the market opportunity and current trends.

Report Structure:

ONE: EXECUTIVE SUMMARY

TWO: INTRODUCTION, NOVEL AND TRADITIONAL APPROACHES

THREE: MARKET DRIVERS / BARRIERS

FOUR: NOVEL THERAPIES IN BLADDER CANCER TREATMENT

FIVE: NOVEL THERAPIES IN BRAIN CANCER TREATMENT

SIX: NOVEL THERAPIES IN BREAST CANCER TREATMENT

SEVEN: NOVEL THERAPIES IN COLORECTAL CANCER TREATMENT115

EIGHT: NOVEL THERAPIES IN KIDNEY CANCER TREATMENT

NINE: NOVEL THERAPIES IN LEUKEMIA TREATMENT

TEN: NOVEL THERAPIES IN LIVER CANCER TREATMENT

ELEVEN: NOVEL THERAPIES IN LUNG CANCER TREATMENT

TWELVE: NOVEL THERAPIES IN LYMPHOMA TREATMENT

THIRTEEN: NOVEL THERAPIES IN MELANOMA TREATMENT

FOURTEEN: NOVEL THERAPIES IN MULTIPLE MYELOMA TREATMENT

FIFTEEN: NOVEL THERAPIES IN PANCREATIC CANCER TREATMENT229

SIXTEEN: NOVEL THERAPIES IN PROSTATE CANCER TREATMENT 239

SEVENTEEN: NOVEL CANCER THERAPIES: MARKET SUMMARY

EIGHTEEN: MARKET PARTICIPANTS AND KEY DEVELOPERS

For more information visit http://www.researchandmarkets.com/research/r2jnfb/the_world_market

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com